Role of Drug Hypersensitivity in the Cutaneous Manifestations of SARS-CoV-2 Infection

J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):218-220. doi: 10.18176/jiaci.0744. Epub 2021 Sep 7.

¹ Allergology Department, Hospital Universitario Ramón y Cajal, IRYCS, Madrid, Spain.
² Dermatology Department Hospital Universitario Ramón y Cajal, IRYCS, Madrid, Spain.
³ Histopathology Department Hospital Universitario Ramón y Cajal, IRYCS, Madrid, Spain.
⁴ Immunology Department Hospital Universitario Ramón y Cajal, IRYCS, Madrid, Spain.
⁵ Biomarkers and Therapeutic Targets Group, RedinRen, Hospital Universitario Ramón y Cajal, IRYCS, Madrid, Spain.
⁶ Spanish Thematic Network and Co-operative Research Centres, ARADyAL, Spain.

No abstract available

Keywords: Cutaneous manifestations; Drug hypersensitivity; Drug provocation test; First wave; SARS-CoV-2.

MeSH terms